Display options
Share it on

Genes (Basel). 2014 Jul 09;5(3):508-17. doi: 10.3390/genes5030508.

Genetic versus Non-Genetic Regulation of miR-103, miR-143 and miR-483-3p Expression in Adipose Tissue and Their Metabolic Implications-A Twin Study.

Genes

Jette Bork-Jensen, Anne Cathrine Baun Thuesen, Claus Heiner Bang-Bertelsen, Louise Groth Grunnet, Flemming Pociot, Henning Beck-Nielsen, Susan E Ozanne, Pernille Poulsen, Allan Vaag

Affiliations

  1. Department of Endocrinology, Diabetes and Metabolism, Rigshospitalet, DK-2200 Copenhagen N, Denmark. [email protected].
  2. Department of Endocrinology, Diabetes and Metabolism, Rigshospitalet, DK-2200 Copenhagen N, Denmark. [email protected].
  3. Department of Clinical and Experimental Research, Glostrup Research Institute, Glostrup University Hospital, DK-2600 Glostrup, Denmark. [email protected].
  4. Department of Endocrinology, Diabetes and Metabolism, Rigshospitalet, DK-2200 Copenhagen N, Denmark. [email protected].
  5. Center for Non-Coding RNA in Technology and Health, Science, University of Copenhagen, DK-2000 Frederiksberg, Denmark. [email protected].
  6. Diabetes Research Center, Odense University Hospital, DK-5000 Odense C, Denmark. [email protected].
  7. University of Cambridge Metabolic Research Laboratories and MRC Metabolic Diseases Unit, Wellcome Trust-MRC Institute of Metabolic Science, Level 4, Box 289, Addenbrookes Treatment Centre, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK. [email protected].
  8. Novo Nordisk, DK-2860 Bagsværd, Denmark. [email protected].
  9. Department of Endocrinology, Diabetes and Metabolism, Rigshospitalet, DK-2200 Copenhagen N, Denmark. [email protected].

PMID: 25010252 PMCID: PMC4198914 DOI: 10.3390/genes5030508

Abstract

Murine models suggest that the microRNAs miR-103 and miR-143 may play central roles in the regulation of subcutaneous adipose tissue (SAT) and development of type 2 diabetes (T2D). The microRNA miR-483-3p may reduce adipose tissue expandability and cause ectopic lipid accumulation, insulin resistance and T2D. We aimed to explore the genetic and non-genetic factors that regulate these microRNAs in human SAT, and to investigate their impact on metabolism in humans. Levels of miR-103, miR-143 and miR-483-3p were measured in SAT biopsies from 244 elderly monozygotic and dizygotic twins using real-time PCR. Heritability estimates were calculated and multiple regression analyses were performed to study associations between these microRNAs and measures of metabolism, as well as between these microRNAs and possible regulating factors. We found that increased BMI was associated with increased miR-103 expression levels. In addition, the miR-103 levels were positively associated with 2 h plasma glucose levels and hemoglobin A1c independently of BMI. Heritability estimates for all three microRNAs were low. In conclusion, the expression levels of miR-103, miR-143 and miR-483-3p in adipose tissue are primarily influenced by non-genetic factors, and miR-103 may be involved in the development of adiposity and control of glucose metabolism in humans.

References

  1. PLoS One. 2010 Feb 02;5(2):e9022 - PubMed
  2. Genome Res. 2009 Jan;19(1):92-105 - PubMed
  3. Horm Res. 2006;65 Suppl 3:137-43 - PubMed
  4. Nat Cell Biol. 2011 Apr;13(4):434-46 - PubMed
  5. Diabetologia. 1999 Jul;42(7):898-9 - PubMed
  6. Diabetologia. 1999 Feb;42(2):139-45 - PubMed
  7. Am J Obstet Gynecol. 2004 Sep;191(3):700-7 - PubMed
  8. Diabetes. 2009 Oct;58(10):2402-8 - PubMed
  9. Cell Death Differ. 2012 Jun;19(6):1003-12 - PubMed
  10. Diabetes. 2009 May;58(5):1050-7 - PubMed
  11. Nat Rev Cancer. 2010 Jun;10(6):389-402 - PubMed
  12. Diabetologia. 2002 Dec;45(12):1649-57 - PubMed
  13. Nature. 2011 Jun 08;474(7353):649-53 - PubMed
  14. Br Med Bull. 2001;60:5-20 - PubMed
  15. Mol Endocrinol. 2009 Jun;23(6):925-31 - PubMed
  16. Biochem Biophys Res Commun. 2008 Nov 28;376(4):728-32 - PubMed
  17. Hum Mol Genet. 2007 May 1;16(9):1124-31 - PubMed
  18. Cell. 2004 Jan 23;116(2):281-97 - PubMed
  19. J Hypertens. 2002 Apr;20(4):645-9 - PubMed
  20. PLoS One. 2009;4(3):e4699 - PubMed
  21. Prog Growth Factor Res. 1995;6(2-4):465-73 - PubMed
  22. Diabetologia. 1985 Jul;28(7):412-9 - PubMed
  23. J Biol Chem. 2008 Jan 4;283(1):332-340 - PubMed
  24. Diabetes. 2009 Jun;58(6):1350-5 - PubMed

Publication Types

Grant support